Cited by 476Gastrointestinal motility and disordersGut microbiota and healthInfant Health and Development

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome

tana, c., umesaki, y., imaoka, a., handa, t., kanazawa, m., fukudo, s.·2009·Neurogastroenterology & Motility

DOI 10.1111/j.1365-2982.2009.01427.x

Open this paper in CoChat — free account

Abstract

BACKGROUND: The profile of intestinal organic acids in irritable bowel syndrome (IBS) and its correlation with gastrointestinal (GI) symptoms are not clear. We hypothesized in this study that altered GI microbiota contribute to IBS symptoms through increased levels of organic acids. METHODS: Subjects were 26 IBS patients and 26 age- and sex-matched controls. Fecal samples were collected for microbiota analysis using quantitative real-time polymerase chain reaction and culture methods, and the determination of organic acid levels using high-performance liquid chromatography. Abdominal gas was quantified by image analyses of abdominal X-ray films. Subjects completed a questionnaire for GI symptoms, quality of life (QOL) and negative emotion. KEY RESULTS: Irritable bowel syndrome patients showed significantly higher counts of Veillonella (P = 0.046) and Lactobacillus (P = 0.031) than controls. They also expressed significantly higher levels of acetic acid (P = 0.049), propionic acid (P = 0.025) and total organic acids (P = 0.014) than controls. The quantity of bowel gas was not significantly different between controls and IBS patients. Finally, IBS patients with high acetic acid or propionic acid levels presented with significantly worse GI symptoms, QOL and negative emotions than those with low acetic acid or propionic acid levels or controls. CONCLUSIONS & INFERENCES: These results support the hypothesis that both fecal microbiota and organic acids are altered in IBS patients. A combination of Veillonella and Lactobacillus is known to produce acetic and propionic acid. High levels of acetic and propionic acid may associate with abdominal symptoms, impaired QOL and negative emotions in IBS.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2982.2009.01427.x

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813
The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure
Bagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90005-1 · Cited by 5,293
Functional Bowel Disorders
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Psychological Stress and Susceptibility to the Common Cold
Cohen, S., Tyrrell, D. A. J., & Smith, A. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108293250903 · Cited by 1,712
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress
FRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
GSRS—A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease
Svedlund, J., Sjödin, I., & Dotevall, G. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01535722 · Cited by 1,319

Show all 45 references

Research works printed but not linked: 2

Speilberger, 1970, STAI Manual, 23
Brierley, 2008, Novel and specific roles for the inon channel TRPA1 in visceral sensory transduction, Gastroenterology, 134

Sorted by citations

Items 101–200 of 476

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
Mazzawi, T., Lied, G. A., Sangnes, D. A., El-Salhy, M., Hov, J. R., Gilja, O. H., Hatlebakk, J. G., & Hausken, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194904 · Cited by 92
Is fecal microbiota transplantation ( FMT ) an effective treatment for patients with functional gastrointestinal disorders ( FGID )?
Pinn, D. M., Aroniadis, O. C., & Brandt, L. J. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12479 · Cited by 93
β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria
Wilson, B., Rossi, M., Kanno, T., Parkes, G. C., Anderson, S., Mason, A. J., Irving, P. M., Lomer, M. C. E., & Whelan, K. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000641 · Cited by 93
Stress and visceral pain: Focusing on irritable bowel syndrome
Fukudo, S. (2013) · Pain · doi:10.1016/j.pain.2013.09.008 · Cited by 94
Self-citation
Effects of rifaximin on transit, permeability, fecal microbiome, and organic acid excretion in irritable bowel syndrome
Acosta, A., Camilleri, M., Shin, A., Nord, S. L., O'Neill, J., Gray, A. V., Lueke, A. J., Donato, L. J., Burton, D. D., Szarka, L. A., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.32 · Cited by 88
Human gut microbiome changes during a 10 week Randomised Control Trial for micronutrient supplementation in children with attention deficit hyperactivity disorder
Stevens, A. J., Purcell, R. V., Darling, K. A., Eggleston, M. J. F., Kennedy, M. A., & Rucklidge, J. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-46146-3 · Cited by 88
Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
Mishima, Y., & Ishihara, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228664 · Cited by 94
Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome
Shaidullov, I. F., Sorokina, D. M., Ситдиков, Ф. Г., Hermann, A., Abdulkhakov, S. R., & Ситдикова, Г. Ф. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01613-y · Cited by 93
Upper gastrointestinal microbiota and digestive diseases
Wang, Z.-K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i10.1541 · Cited by 90
Dietary Interventions to Modulate the Gut Microbiome—How Far Away Are We From Precision Medicine
Filippis, F. D., Vitaglione, P., Cuomo, R., Canani, R. B., & Ercolini, D. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy080 · Cited by 90
Gene, environment, and brain‐gut interactions in irritable bowel syndrome
Fukudo, S., & Kanazawa, M. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06631.x · Cited by 87
Self-citation
Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles
Coulson, S., Butt, H., Vecchio, P. C., Gramotnev, H., & Vitetta, L. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0146-4 · Cited by 86
The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials
Niu, H.-L., & Xiao, J. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.01.142 · Cited by 90
Next-generation sequencing technologies and their impact on microbial genomics
Forde, B. M., & O’Toole, P. W. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els062 · Cited by 91
Abdominal Bloating: Pathophysiology and Treatment
Seo, A. Y., Kim, N., & Oh, D. H. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.4.433 · Cited by 82
Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota
Altomare, A., Putignani, L., CHIERICO, F. D., Cocca, S., Angeletti, S., Ciccozzi, M., Tripiciano, C., Piccola, B. D., Cicala, M., & Guarino, M. P. L. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.11.021 · Cited by 86
Bifidobacterium pseudocatenulatum CECT 7765 ameliorates neuroendocrine alterations associated with an exaggerated stress response and anhedonia in obese mice
Agusti, A., Moya-Pérez, A., Campillo, I., Montserrat-de la Paz, S., Cerrudo, V., Perez-Villalba, A., & Sanz, Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0768-z · Cited by 85
Mucin O-glycan-microbiota axis orchestrates gut homeostasis in a diarrheal pig model
Xia, B., Zhong, R., Wu, W., Luo, C., Meng, Q., Gao, Q., Zhao, Y. M., Chen, L., Zhang, S., Zhao, X., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01326-8 · Cited by 88
Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment
Filippis, A. D., Ullah, H., Baldi, A., Dacrema, M., Esposito, C., Garzarella, E. U., Santarcangelo, C., Tantipongpiradet, A., & Daglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144929 · Cited by 87
Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome
Theodorou, V., Ait-Belgnaoui, A., Agostini, S., & Eutamene, H. (2014) · Gut Microbes · doi:10.4161/gmic.29796 · Cited by 83
Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83
Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta‐analysis
Myneedu, K., Deoker, A., Schmulson, M. J., & Bashashati, M. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619866990 · Cited by 82
Microbiota: a novel regulator of pain
Defaye, M., Gervason, S., Altier, C., Berthon, J., Ardid, D., Filaire, E., & Carvalho, F. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02083-z · Cited by 81
The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study
Ohtsu, T., Takagi, A., Uemura, N., Inoue, K., Sekino, H., Kawashima, A., Uchida, M., & Koga, Y. (2017) · Digestion · doi:10.1159/000479000 · Cited by 79
Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016
Layer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 81
Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome
Michail, S. K., & Kenche, H. (2010) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-010-9059-y · Cited by 78
Unraveling the Functions of the Macroalgal Microbiome
Singh, R. P., & Reddy, C. R. K. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01488 · Cited by 83
Usefulness of Machine Learning-Based Gut Microbiome Analysis for Identifying Patients with Irritable Bowels Syndrome
Fukui, H., Nishida, A., Matsuda, S., Kira, F., Watanabe, S., Kuriyama, M., Kawakami, K., Aikawa, Y., Oda, N., Arai, K., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082403 · Cited by 80
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome
Żeber‐Lubecka, N., Kulecka, M., Ambrożkiewicz, F., Paziewska, A., Goryca, K., Karczmarski, J., Rubel, T., Wojtowicz, W., Młynarz, P., Marczak, Ł., et al. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1215805 · Cited by 77
Effects of Bifidobacterium infantis 35624 on Post-Inflammatory Visceral Hypersensitivity in the Rat
Johnson, A. C., Greenwood-Van Meerveld, B., & McRorie, J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1730-y · Cited by 76
Rethinking Short-Chain Fatty Acids: A Closer Look at Propionate in Inflammation, Metabolism, and Mucosal Homeostasis
Facchin, S., Calgaro, M., & Savarino, E. V. (2025) · Cells · doi:10.3390/cells14151130 · Cited by 75
Unraveling the ties between irritable bowel syndrome and intestinal microbiota
Hong, S. N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2470 · Cited by 76
Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Lopez, J., & Grinspan, A. M. (2016) · PubMed Central · Cited by 75
The Role of the Human Microbiome in the Pathogenesis of Pain
Ustianowska, K., Ustianowski, Ł., Machaj, F., Gorący, A., Rosik, J., Szostak, B., Szostak, J., & Pawlik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113267 · Cited by 77
Intestinal microbiome in children with severe and complicated acute viral gastroenteritis
Chen, S.-Y., Tsai, C., Lee, Y.-S., Lin, C., Huang, K.-Y., Chao, H., Lai, M., & Chiu, C. (2017) · Scientific Reports · doi:10.1038/srep46130 · Cited by 74
The role of the brain–gut–microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders
Ganci, M., Suleyman, E., Butt, H., & Ball, M. (2019) · Brain and Behavior · doi:10.1002/brb3.1408 · Cited by 75
An investigation into blood microbiota and its potential association with Bacterial Chondronecrosis with Osteomyelitis (BCO) in Broilers
Mandal, R. K., Jiang, T., Alrubaye, A. A. K., Rhoads, D. D., Wideman, R. F., Jr., Zhao, J., Pevzner, I. Y., & Kwon, Y. M. (2016) · Scientific Reports · doi:10.1038/srep25882 · Cited by 70
Altered intestinal microbiota in irritable bowel syndrome: Microbiota in IBS
Lee, K. J., & Tack, J. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01482.x · Cited by 69
Acid-sensing ion channels in gastrointestinal function
Holzer, P. D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.009 · Cited by 69
Effectiveness and Safety of a Probiotic-Mixture for the Treatment of Infantile Colic: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial with Fecal Real-Time PCR and NMR-Based Metabolomics Analysis
Baldassarre, M. E., Mauro, A. D., Tafuri, S., Rizzo, V., Gallone, M. F., Mastromarino, P., Capobianco, D., Laghi, L., Zhu, C., Capozza, M., et al. (2018) · Nutrients · doi:10.3390/nu10020195 · Cited by 69
Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols
Valeur, J., Røseth, A. G., Knudsen, T., Malmstrøm, G. H., Fiennes, J. T., Midtvedt, T., & Berstad, A. (2016) · Digestion · doi:10.1159/000448280 · Cited by 68
Gut Microbiota Markers and Dietary Habits Associated with Extreme Longevity in Healthy Sardinian Centenarians
Palmas, V., Pisanu, S., Madau, V., Casula, E., Deledda, A., Cusano, R., Uva, P., Loviselli, A., Velluzzi, F., & Manzin, A. (2022) · Nutrients · doi:10.3390/nu14122436 · Cited by 68
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options
Bonfrate, L., Tack, J. F., Grattagliano, I., Cuomo, R., & Portincasa, P. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.799220 · Cited by 69
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
Ludidi, S., Mujagic, Z., Jonkers, D. M. A. E., Keszthelyi, D., Hesselink, M., Kruimel, J. W., Conchillo, J. M., & Masclee, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12365 · Cited by 66
The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome
Jiang, W., Wu, J., Zhu, S., Xin, L., Yu, C., & Shen, Z. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22093 · Cited by 70
Intestinal Microbiota Predicts Lung Cancer Patients at Risk of Immune-Related Diarrhea
Liu, T., Xiong, Q., Li, L., & Hu, Y. (2019) · Immunotherapy · doi:10.2217/imt-2018-0144 · Cited by 64
Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects
Rinttilä, T., Lyra, A., Krogius-Kurikka, L., & Palva, A. (2011) · Gut Pathogens · doi:10.1186/1757-4749-3-6 · Cited by 63
Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders
Shimura, S., Ishimura, N., Mikami, H., Okimoto, E., Uno, G., Tamagawa, Y., Aimi, M., Oshima, N., Sato, S., Ishihara, S., et al. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15116 · Cited by 63
Dietary xylo-oligosaccharide supplementation alters gut microbial composition and activity in pigs according to age and dose
Pan, J., Yin, J., Zhang, K., Xie, P., Ding, H., Huang, X., Blachier, F., & Kong, X. (2019) · AMB Express · doi:10.1186/s13568-019-0858-6 · Cited by 65
Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases
Sundin, J., Öhman, L., & Simrén, M. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000470 · Cited by 61
Overview of the rules of the microbial engagement in the gut microbiome: a step towards microbiome therapeutics
Yadav, M., & Chauhan, N. S. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14883 · Cited by 60
Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines
Zhou, Y., Zhang, F., Mao, L., Feng, T., Wang, R. C., Xu, M., Lv, B., & Wang, X. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02958-0 · Cited by 61
Faecal short-chain fatty acid pattern in childhood coeliac disease is normalised after more than one year's gluten-free diet
Tjellström, B., Högberg, L., Stenhammar, L., Fälth‐Magnusson, K., Magnusson, K., Norin, E. L., Sundqvist, T., & Midtvedt, T. (2013) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v24i0.20905 · Cited by 59
Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients
Thorkildsen, L. T., Nwosu, F. C., Avershina, E., Ricanek, P., Perminow, G., Brackmann, S., Vatn, M. H., & Rudi, K. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/636785 · Cited by 59
Chemoprevention in Gastrointestinal Physiology and Disease. Natural products and microbiome
Greiner, A. K., Papineni, R. V. L., & Umar, S. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00044.2014 · Cited by 60
IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation
Maccaferri, S., Candela, M., Turroni, S., Centanni, M., Severgnini, M., Consolandi, C., Cavina, P., & Brigidi, P. (2012) · Gut Microbes · doi:10.4161/gmic.21009 · Cited by 57
What’s bugging your teen?—The microbiota and adolescent mental health
McVey Neufeld, K.-A., Luczynski, P., Seira Oriach, C., Dinan, T. G., & Cryan, J. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.005 · Cited by 56
Role of the duodenal microbiota in functional dyspepsia
Brown, G., Hoedt, E. C., Keely, S., Shah, A., Walker, M. M., Holtmann, G., & Talley, N. J. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14372 · Cited by 58
Guidelines on the management of irritable bowel syndrome
Pietrzak, A. M., Skrzydło-Radomańska, B., Mulak, A., Lipiński, M., Malecka-Panas, E. I., Reguła, J., & Rydzewska, G. M. (2018) · Gastroenterology Review · doi:10.5114/pg.2018.78343 · Cited by 60
Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers
Keshteli, A. H., Madsen, K. L., Mandal, R., Boeckxstaens, G. E., Berčík, P., Palma, G. D., Reed, D. E., Wishart, D. S., Vanner, S. J., & Dieleman, L. A. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15141 · Cited by 56
Microbiota and chronic inflammatory arthritis: an interwoven link
Diamanti, A. P., Rosado, M. M., Laganà, B., & D’Amelio, R. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0989-3 · Cited by 54
Effect of Breadmaking Process on In Vitro Gut Microbiota Parameters in Irritable Bowel Syndrome
Costabile, A., Santarelli, S., Claus, S. P., Sanderson, J., Hudspith, B. N., Brostoff, J., Ward, J. L., Lovegrove, A., Shewry, P. R., Jones, H. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111225 · Cited by 52
Electrophysiological Mechanisms of Gastrointestinal Arrhythmogenesis: Lessons from the Heart
Tse, G., Lai, E. T. H., Lee, A. P., Yan, B. P., & Wong, S. H. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00230 · Cited by 52
Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach
Brasili, E., Hassimotto, N. M. A., CHIERICO, F. D., Marini, F., Quagliariello, A., Sciubba, F., Miccheli, A., Putignani, L., & Lajolo, F. M. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05408 · Cited by 52
The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome
Tian, Z., Zhuang, X., Luo, M., Yin, W. H., & Xiong, L. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01212-3 · Cited by 54
Mechanisms of Electrical Activation and Conduction in the Gastrointestinal System: Lessons from Cardiac Electrophysiology
Tse, G., Lai, E. T. H., Yeo, J. M., Tse, V., & Wong, S. H. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00182 · Cited by 51
Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
Zhang, Z., Cong, L., Peng, R., Han, P., Ma, S., Pan, L., Fu, J., Yu, H., Wang, Y., & Jiang, J. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.10.001 · Cited by 50
A preliminary study of gut dysbiosis in children with food allergy
Inoüe, R., Sawai, T., Sawai, C., Nakatani, M., Romero‐Pérez, G. A., Ozeki, M., Nonomura, K., & Tsukahara, T. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1383849 · Cited by 50
Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model
Chen, B., Du, L., He, H., Kim, J. J., Zhao, Y. S., Zhang, Y., Luo, L., & Dai, N. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8321 · Cited by 49
Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome
El‐Salhy, M., Kristoffersen, A. B., Valeur, J., Casèn, C., Hatlebakk, J. G., Gilja, O. H., & Hausken, T. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14200 · Cited by 49
The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection
Singh, R., Nieuwdorp, M., ten Berge, I. J. M., Bemelman, F. J., & Geerlings, S. E. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12799 · Cited by 50
From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome
Rodríguez-Fandíño, O., Hernández-Ruíz, J., & Schmulson, M. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.4.363 · Cited by 54
Caecal pH is a biomarker of excessive colonic fermentation
Farmer, A. D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i17.5000 · Cited by 47
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics
Dothel, G., Barbaro, M. R., Vito, A. D., Ravegnini, G., Gorini, F., Monesmith, S., Coschina, E., Benuzzi, E., Fuschi, D., Palombo, M., et al. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-01997-6 · Cited by 49
Irritable bowel syndrome: The evolution of multi-dimensional looking and multidisciplinary treatments
Chang, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2499 · Cited by 46
A novel biomarker panel for irritable bowel syndrome and the application in the general population
Mujagic, Z., Tigchelaar, E. F., Zhernakova, A., Ludwig, T. G., Ramiro‐Garcia, J., Baranska, A., Swertz, M. A., Masclee, A., Wijmenga, C., van Schooten, F., et al. (2016) · Scientific Reports · doi:10.1038/srep26420 · Cited by 50
Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma
Bingula, R., Filaire, M., Radosevic‐Robin, N., Berthon, J., Bernalier‐Donadille, A., Vasson, M., Thivat, É., Kwiatkowski, F., & Filaire, E. (2018) · Medicine · doi:10.1097/md.0000000000013676 · Cited by 46
Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
Camilleri, M., Halawi, H., & Oduyebo, I. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1288096 · Cited by 45
The gut microbiome and irritable bowel syndrome: State of art review
Salem, A., Singh, R., Ayoub, Y. K., Khairy, A. M., & Mullin, G. E. (2018) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2018.02.008 · Cited by 45
Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
El‐Salhy, M., Casèn, C., Valeur, J., Hausken, T., & Hatlebakk, J. G. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i18.2219 · Cited by 47
Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome
Liu, Y., Li, W., Yang, H., Zhang, X., Wang, W., Jia, S., Xiang, B., Wang, Y., Miao, L., Zhang, H., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.645951 · Cited by 45
Enteric glial cells are associated with stress‐induced colonic hyper‐contraction in maternally separated rats
Fujikawa, Y., Tominaga, K., Tanaka, F., Tanigawa, T., Watanabe, T., Fujiwara, Y., & Arakawa, T. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12577 · Cited by 43
A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
Ahluwalia, B., Iribarren, C., Magnusson, M. K., Sundin, J., Clevers, E., Savolainen, O. I., Ross, A. B., Törnblom, H., Simrén, M., & Öhman, L. (2021) · Cells · doi:10.3390/cells10061459 · Cited by 46
Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels
Mazzawi, T. R. E., Hausken, T., Hov, J. R., Valeur, J., Sangnes, D. A., El‐Salhy, M., Gilja, O. H., Hatlebakk, J. G., & Lied, G. A. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1624815 · Cited by 43
Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis
Luo, M., Zhuang, X., Tian, Z., & Xiong, L. (2021) · BMC Gastroenterology · doi:10.1186/s12876-020-01577-5 · Cited by 45
Current status of fecal microbiota transplantation for irritable bowel syndrome
El‐Salhy, M., Hausken, T., & Hatlebakk, J. G. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14157 · Cited by 45
Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome
Chen, Q., Zhang, H., Sun, C., He, Q., Zhang, R.-R., Luo, B.-F., Zhou, Z., & Chen, X. (2023) · Molecular Medicine · doi:10.1186/s10020-022-00599-x · Cited by 42
An update on irritable bowel syndrome: from diagnosis to emerging therapies
CHANG, J. Y., & Talley, N. J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283414065 · Cited by 42
Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome
Fourie, N. H., Wang, D., Abey, S. K., Creekmore, A. L., Hong, S., Martin, C. G., Wiley, J. W., & Henderson, W. A. (2017) · Gut Microbes · doi:10.1080/19490976.2016.1273999 · Cited by 40
Bovine immunoglobulin protein isolates for the nutritional management of enteropathy
Petschow, B. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11713 · Cited by 40
Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome
Mujagic, Z., Jonkers, D. M. A. E., Ludidi, S., Keszthelyi, D., Hesselink, M., Weerts, Z. Z. R. M., Kievit, R. N., Althof, J. F., Leue, C., Kruimel, J. W., et al. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13137 · Cited by 41
Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome
Singh, P., & Lembo, A. J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.03.003 · Cited by 39
Breath methane in functional constipation: response to treatment with Ispaghula husk
Vega, A.-B., Juan, A. P., Martos, L., Bayo, I., García, M. A., Andreu, V., Abad, A., & Barenys, M. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12568 · Cited by 39
Treatment of Dientamoeba fragilis in Patients with Irritable Bowel Syndrome
Engsbro, A. L., Stensvold, C. R., Nielsen, H. V., & Bytzer, P. M. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0761 · Cited by 39
Mechanisms of Stress‐Induced Visceral Pain: Implications in Irritable Bowel Syndrome
Meerveld, B. G., Moloney, R. D., Johnson, A. C., & Vicario, M. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12361 · Cited by 39
Review of mechanisms of deoxynivalenol‐induced anorexia: The role of gut microbiota
Peng, Z., Chen, L., Xiao, J., Zhou, X., Nussler, A. K., Liu, L., Liu, J., & Yang, W. Q. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3475 · Cited by 39
Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome
James, C. S., Fraser, K., Young, W., McNabb, W. C., & Roy, N. C. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz302 · Cited by 41
Saccharomyces boulardii CNCM I‐745 modulates the microbiota–gut–brain axis in a humanized mouse model of Irritable Bowel Syndrome
Constante, M., Palma, G. D., Lu, J., Jury, J., Rondeau, L. E., Caminero, A., Collins, S. M., Verdu, E. F., & Berčík, P. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13985 · Cited by 41
Cinnamic acid suppresses bone loss via induction of osteoblast differentiation with alteration of gut microbiota
Hong, S., Hyun, K., Park, J. H., Jung, D. S., Choi, J., Yoo, G., & Nho, C. W. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108900 · Cited by 39
A Combined Nutrient and Lactulose Challenge Test Allows Symptom-Based Clustering of Patients With Irritable Bowel Syndrome
Nevé, B. L., Posserud, I., Böhn, L., Guyonnet, D., Rondeau, P., Tillisch, K., Naliboff, B. D., Mayer, E. A., & Simrén, M. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.75 · Cited by 40

Authors: tana, C., umesaki, Y., imaoka, A., handa, T., kanazawa, M., & fukudo, S.
Affiliations: Tohoku University (JP)
Yakult Central Institute (JP)
Corresponding author: fukudo, s.
ORCID: umesaki, y.
Venue: Neurogastroenterology & Motility
Publisher: Wiley
Published: 2009-11
Volume: 22
Issue: 5
Pages: 512-9, e114
ISSN: 1350-1925 (ISSN-L)
1365-2982
DOI: 10.1111/j.1365-2982.2009.01427.x
OpenAlex: W1974577714
Cited by: 474
References: 45
Citations by year: 2026: 6 · 2025: 21 · 2024: 30 · 2023: 19 · 2022: 35 · 2021: 38 · 2020: 31 · 2019: 34 · 2018: 27 · 2017: 29 · 2016: 39 · 2015: 32 · 2014: 38 · 2013: 29 · 2012: 23
FWCI: 23.01
Type: journal article
Language: en
Open access: closed
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2130 d)
Locations: Neurogastroenterology & Motility (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
Keywords: irritable bowel syndrome, gut microbiota, organic acids, acetic acid, propionic acid, Veillonella, Lactobacillus, gastrointestinal symptoms, quality of life, negative emotions, abdominal gas, fecal microbiota
MeSH terms: Adult, Analysis of Variance, Chromatography, High Pressure Liquid, DNA, Bacterial, Feces, Female, Humans, Immunoenzyme Techniques, Lactobacillus, Male, Propionates, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Veillonella, Case-Control Studies, Statistics, Nonparametric, Acetic Acid, Reverse Transcriptase Polymerase Chain Reaction, Irritable Bowel Syndrome, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks